Clinical Roundup Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment June 26, 2026Vol.52 No.25
Clinical Roundup Neutrophils help triple-negative breast cancer cells spread to other organs, BCM study finds June 26, 2026Vol.52 No.25
Clinical Roundup GABA boosts cancer-protecting immune cells in females with glioblastoma, preclinical study finds June 26, 2026Vol.52 No.25
Drugs & Targets EC approves Padcev + Keytruda as perioperative treatment option for cisplatin-ineligible patients with resectable muscle-invasive bladder cancer June 26, 2026Vol.52 No.25
Regulatory News Is psilocybin heading to a cancer clinic near you?Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research June 18, 2026Vol.52 No.24By Sara Willa Ernst
Trials & Tribulations What NHS-Galleri taught us—and what it didn’t June 18, 2026Vol.52 No.24By Scott D. Ramsey and Ruth Etzioni
Trials & Tribulations The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies June 18, 2026Vol.52 No.24By Bryan Bassig, Catherine R. Marinac, David M. Routman, Elizabeth K. O'Donnell, Jennifer Keating Litton, Karthik V. Giridhar, Kennedy Ng Yao Yi, Kurt Giles, Nima Nabavizadeh, Ora K. Gordon, Rebecca Kaltman and Shawn Kothari